I might be missing something but I don't understand why there needs to be a combination of Sarepta's drug with ours.
Their drug did no better than placebo whilst ours reduced inflammation and stabilised or reduced fat.
Why charge the victims of this disease for two drugs when only one seems to be helping.
Research note, page-88
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
-0.002(2.44%) |
Mkt cap ! $82.94M | |||
| Open | High | Low | Value | Volume |
| 8.3¢ | 8.3¢ | 7.9¢ | $287.6K | 3.558M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 939854 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 277962 | 1 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |